« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6
, Pages 1154-1160
, December 2008
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy
References
- . Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol. 1999;103:981–989
- . A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol. 2001;108:128–132
- . The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000;137:749–755
- Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol. 2006;118:466–472
- . Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119:1016–1018
- . Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107:191–193
- . Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007;119:1018–1019
- . Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327:380–384
- Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol. 2007;119:199–205
- Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. 2005;116:1073–1079
- Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol. 2008;121:343–347
- . A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy. 2004;59:980–987
- Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol. 2007;39:12–19
- Oral specific desensitization in food-allergic children. Dig Dis Sci. 2007;52:1662–1672
- Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther. 2003;17:459–465
- . Food allergy in children: Results of a standardized protocol for oral desensitization. Hepatogastroenterology. 1998;45:52–58
- . Specific oral tolerance induction in food allergy in children: Efficacy and clinical patterns of reaction. Allergy. 2007;62:1261–1269
- . Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics. 1987;79:683–688
- . A prospective study of cow milk allergy in Danish infants during the first 3 years of life. clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy. 1990;45:587–596
- Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. J Allergy Clin Immunol. 1999;104:457–461
- . Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. Eur J Pediatr. 1993;152:640–644
- . Natural history of cow milk allergy: clinical outcome. J Pediatr. 1990;116:862–867
- . The spectrum of cow's milk allergy in childhood. clinical, gastroenterological and immunological studies. Acta Paediatr Scand. 1979;68:847–852
- . Natural history of cows' milk allergy in children: immunological outcome over 2 years. Clin Exp Allergy. 1993;23:124–131
- . Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol. 2005;116:869–875
- . The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol. 2007;120:1172–1177
Supported by National Institutes of Health (NIH) training grant no. 5T32 AI07007, the Eudowood Foundation, NIH training grant no. 5T32AI007062-30, and Duke Clinical Research Unit/Clinical and Translational Science Award grant no. 5UL1-RR024128-02.
Disclosure of potential conflict of interest: A. W. Burks has consulting arrangements with ActoGeniX, NV, Novartis, McNeil Nutritionals, and Mead Johnson; owns stock in Allertein and MastCell, Inc; is on the advisory board for Dannon Co, Probiotics; is on the speakers' bureau for EpiPen/Dey; is on the data-monitoring committee for Genentech; is on an expert panel for Nutricia; has received research support from the National Institutes of Health (NIH), the Food Allergy and Anaphylaxis Network (FAAN), Gerber, and Mead Johnson; has served as an expert witness in food allergy litigation; and has served as a member of the FAAN, the American College of Allergy, Asthma & Immunology, the NIH, Hypersensitivity, Autoimmune, and Immune-mediated Diseases, and the Journal of Allergy and Clinical Immunology. R. A. Wood has received research support from Genentech and is on the advisory board for the FAAN and Dey. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01725-9
doi: 10.1016/j.jaci.2008.09.030
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6
, Pages 1154-1160
, December 2008
